The reform states that only a prescription will be required for the following ten indications: for oncology patients during chemotherapy or radiation treatments; patients with inflammatory bowel disease; multiple sclerosis patients; Parkinson’s patients; Tourette’s Syndrome; AIDS patients; epilepsy; Autism spectrum disorder; dementia; Terminally ill patients. In situations of post-traumatic stress (PTSD), pain and other medical conditions, a license will be required along with a prescription that will be issued through the health fund.
“Israel is among the leading countries in regulating the treatment of medical cannabis,” he said Eli Cohen, CEO of Klalit Health Services, “The aim of the reform is to ease the existing regulation in the field while maintaining the health of the patients and the safety of the treatment. In the last few months, we prepared for the implementation of the reform through Moore, who was chosen to coordinate and manage the entire procedure for the patients. Mor will be a single address that will centralize the treatment regarding the issuance of the prescription or license. Our goal is to make the process easier for Klalit’s patients, who make up about half of all medical cannabis license holders.”
From the moment the patient receives a recommendation from a specialist in his field for the treatment of medical cannabis, the patient will submit an application in the digital system established by Moore. Upon submission, it is forwarded for processing with a commitment to a quick response of up to 5 days.
Holders of a valid license who are supposed to switch to a prescription route from a doctor can choose to switch to a prescription route as of April 1 or when their license expires. The Ministry of Health also stated that the treatment fee for issuing a prescription will cost 180 NIS, and the rate for issuing a license will be 360 NIS.